Warning letter
Peter Schiff Enterprises: warning letter of Jan 7, 2005
FDA warning letter UCM075241 · New Orleans District Office
Key facts
| Reference number | UCM075241 |
|---|---|
| Company | Peter Schiff Enterprises |
| Subject | Current Good Manufacturing Practice/Adulterated |
| Issue date | Jan 7, 2005 |
| Posted date | Jan 7, 2005 |
| Issuing office | New Orleans District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Cookeville |
| Inspection ZIP | 38506 |
| Inspection start date | Nov 16, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: